BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

  1. Homepage
  2. Medicinal products
  3. Pharmacovigilance
  4. Risk information

Ondansetron: contraindications and interactions if used concomitantly with apomorphine

2015.10.30

Active substance: ondansetron

30.10.2015 - Notice within the graduated plan procedure ("Stufenplanverfahren")

BfArM issues a notice within the graduated plan procedure ("Stufenplanbescheid") concerning the implementation of information on contraindications and interactions if used concomitantly with apomorphine.

09.07.2015 - Hearing within the graduated plan procedure ("Stufenplanverfahren")

The BfArM has initiated a graduated plan procedure (Stufenplan) in order to ensure inclusion and standardised wording of the contraindication for ondansetron and concomitant administration of apomorphine in all product informations of medicinal products containing ondansetron.

Further information

to the graduated plan procedure (available in German only)